Page last updated: 2024-10-29

staurosporine aglycone and Diabetic Neuropathies

staurosporine aglycone has been researched along with Diabetic Neuropathies in 1 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, XH1
Byun, HS1
Chen, SR1
Cai, YQ1
Pan, HL1

Other Studies

1 other study available for staurosporine aglycone and Diabetic Neuropathies

ArticleYear
Reduction in voltage-gated K+ channel activity in primary sensory neurons in painful diabetic neuropathy: role of brain-derived neurotrophic factor.
    Journal of neurochemistry, 2010, Sep-01, Volume: 114, Issue:5

    Topics: Action Potentials; Animals; Brain-Derived Neurotrophic Factor; Carbazoles; Diabetes Mellitus, Experi

2010